These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 27410033)

  • 1. Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis.
    Tian Y; Ma Z; Chen Z; Li M; Wu Z; Hong M; Wang H; Svatek R; Rodriguez R; Wang Z
    PLoS One; 2016; 11(7):e0158891. PubMed ID: 27410033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Ki-67 Immunohistochemical Reactivity Correlates With Poor Prognosis in Bladder Carcinoma: A Comprehensive Meta-Analysis with 13,053 Patients Involved.
    Luo Y; Zhang X; Mo M; Tan Z; Huang L; Zhou H; Wang C; Wei F; Qiu X; He R; Chen G
    Medicine (Baltimore); 2016 Apr; 95(15):e3337. PubMed ID: 27082587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of different cut-off levels of Ki-67 in breast cancer: a systematic review and meta-analysis of 64,196 patients.
    Petrelli F; Viale G; Cabiddu M; Barni S
    Breast Cancer Res Treat; 2015 Oct; 153(3):477-91. PubMed ID: 26341751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of CK20 and Ki-67 immunostaining analysis predicts recurrence, progression, and cancer-specific survival in pT1 urothelial bladder cancer.
    Bertz S; Otto W; Denzinger S; Wieland WF; Burger M; Stöhr R; Link S; Hofstädter F; Hartmann A
    Eur Urol; 2014 Jan; 65(1):218-26. PubMed ID: 22633802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ki-67 as a prognostic marker in early-stage non-small cell lung cancer in Asian patients: a meta-analysis of published studies involving 32 studies.
    Wen S; Zhou W; Li CM; Hu J; Hu XM; Chen P; Shao GL; Guo WH
    BMC Cancer; 2015 Jul; 15():520. PubMed ID: 26174366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic significance of long noncoding RNAs in bladder cancer: A meta-analysis.
    Xia Y; Liu Z; Yu W; Zhou S; Shao L; Song W; Liu M
    PLoS One; 2018; 13(6):e0198602. PubMed ID: 29870555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs with prognostic significance in bladder cancer: a systematic review and meta-analysis.
    Xie Y; Ma X; Chen L; Li H; Gu L; Gao Y; Zhang Y; Li X; Fan Y; Chen J; Zhang X
    Sci Rep; 2017 Jul; 7(1):5619. PubMed ID: 28717125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy.
    Zlotta AR; Noel JC; Fayt I; Drowart A; Van Vooren JP; Huygen K; Simon J; Schulman CC
    J Urol; 1999 Mar; 161(3):792-8. PubMed ID: 10022686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic role of Ki-67/MIB-1 in cervical cancer: a systematic review with meta-analysis.
    Pan D; Wei K; Ling Y; Su S; Zhu M; Chen G
    Med Sci Monit; 2015 Mar; 21():882-9. PubMed ID: 25807305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is Overexpression of Ki-67 a Prognostic Biomarker of Upper Tract Urinary Carcinoma? A Retrospective Cohort Study and Meta-Analysis.
    Fan B; Zhang H; Jin H; Gai Y; Wang H; Zong H; Jin M; Yang H; Wan S; Zhu J; Xu S; Wang J; Yang D; Song X
    Cell Physiol Biochem; 2016; 40(6):1613-1625. PubMed ID: 28006766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of molecular markers, sub-stage and European Organisation for the Research and Treatment of Cancer risk scores in primary T1 bladder cancer.
    van Rhijn BW; Liu L; Vis AN; Bostrom PJ; Zuiverloon TC; Fleshner NE; van der Aa MN; Alkhateeb SS; Bangma CH; Jewett MA; Zwarthoff EC; Bapat B; van der Kwast TH; Zlotta AR
    BJU Int; 2012 Oct; 110(8):1169-76. PubMed ID: 22448597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
    Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of Ki-67 is a poor prognostic marker for colorectal cancer patients: a meta analysis.
    Luo ZW; Zhu MG; Zhang ZQ; Ye FJ; Huang WH; Luo XZ
    BMC Cancer; 2019 Feb; 19(1):123. PubMed ID: 30727976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do molecular biomarkers have prognostic value in primary T1G3 bladder cancer treated with bacillus Calmette-Guerin intravesical therapy?
    Park J; Song C; Shin E; Hong JH; Kim CS; Ahn H
    Urol Oncol; 2013 Aug; 31(6):849-56. PubMed ID: 21782482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ki-67 is an independent indicator in non-muscle invasive bladder cancer (NMIBC); combination of EORTC risk scores and Ki-67 expression could improve the risk stratification of NMIBC.
    Ding W; Gou Y; Sun C; Xia G; Wang H; Chen Z; Tan J; Xu K; Qiang D
    Urol Oncol; 2014 Jan; 32(1):42.e13-9. PubMed ID: 24360660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmented expression of Ki-67 is correlated with clinicopathological characteristics and prognosis for lung cancer patients: an up-dated systematic review and meta-analysis with 108 studies and 14,732 patients.
    Wei DM; Chen WJ; Meng RM; Zhao N; Zhang XY; Liao DY; Chen G
    Respir Res; 2018 Aug; 19(1):150. PubMed ID: 30103737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced E-cadherin expression is correlated with poor prognosis in patients with bladder cancer: a systematic review and meta-analysis.
    Xie Y; Li P; Gao Y; Gu L; Chen L; Fan Y; Zhang F; Zhang X
    Oncotarget; 2017 Sep; 8(37):62489-62499. PubMed ID: 28977963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic role of matrix metalloproteinases in bladder carcinoma: a systematic review and meta-analysis.
    Miao C; Liang C; Zhu J; Xu A; Zhao K; Hua Y; Zhang J; Chen W; Suo C; Zhang C; Liu Y; Su S; Wang Z
    Oncotarget; 2017 May; 8(19):32309-32321. PubMed ID: 28427222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic and prognostic significance of p21 (Cip1/Waf1) expression in bladder cancer.
    Tang K; Wang C; Chen Z; Xu H; Ye Z
    Int J Clin Exp Pathol; 2015; 8(5):4999-5007. PubMed ID: 26191193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ki-67 is an independent predictor of bladder cancer outcome in patients treated with radical cystectomy for organ-confined disease.
    Margulis V; Shariat SF; Ashfaq R; Sagalowsky AI; Lotan Y
    Clin Cancer Res; 2006 Dec; 12(24):7369-73. PubMed ID: 17189409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.